Tuesday, September 7, 2021

Four independent studies show rovalpituzumab tesirine ineffective against small cell lung cancer

Four independent studies demonstrate that rovalpituzumab tesirine for small-cell lung cancer (SCLC) is not effective against SCLC, casting a pall over the future of the therapy and closing a door that seemed opened four years ago when the first study on the therapy was published.

from Top Health News -- ScienceDaily https://ift.tt/2YtWLZv
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Millions of exploding stars could soon reveal dark energy's secrets

A new AI-powered framework could transform how astronomers measure the expansion of the Universe. By analyzing images of Type Ia supernovae ...